Guardforce AI (NASDAQ: GFAI) reports Nasdaq minimum bid price non-compliance
Rhea-AI Filing Summary
Guardforce AI Co., Limited disclosed that it received a notice from Nasdaq on December 12, 2025 stating that its ordinary shares no longer meet the exchange’s minimum bid price requirement for continued listing. Nasdaq rules require a minimum bid price of US$1.00 per share, measured over 30 consecutive business days, and the company’s shares were below this level from October 30 through December 11, 2025.
The company has 180 calendar days, until June 10, 2026, to regain compliance by maintaining a closing bid price of at least US$1.00 for a minimum of 10 consecutive trading days. If it does not regain compliance by that date, it may be eligible for additional time or could face delisting from Nasdaq. The notice does not immediately affect trading, and the shares continue to trade on Nasdaq under the ticker “GFAI.” Guardforce AI plans to monitor its share price and is considering measures to improve its financial position and operations, which it expects will help address the deficiency.
Positive
- None.
Negative
- Nasdaq minimum bid price deficiency: Guardforce AI’s shares traded below the required US$1.00 minimum bid price for 30 consecutive business days through December 11, 2025, triggering a formal non-compliance notice and creating potential delisting risk if compliance is not restored by June 10, 2026.
Insights
Nasdaq bid-price deficiency introduces listing risk if compliance is not restored.
Guardforce AI reports that its shares failed to meet Nasdaq’s
This notice has no immediate impact on trading status; the shares continue to trade on Nasdaq under ticker “GFAI.” However, if the company does not regain compliance by June 10, 2026, Nasdaq may delist the shares, unless an additional compliance period is granted under the rules. The company states that it is monitoring its closing bid price and is considering measures to improve its financial position and results of operations, which it expects could help address the deficiency.
From an investor perspective, the key milestone is the